372 related articles for article (PubMed ID: 1776129)
1. Heterogeneous binding of [3H]4-DAMP to muscarinic cholinergic sites in the rat brain: evidence from membrane binding and autoradiographic studies.
Araujo DM; Lapchak PA; Quirion R
Synapse; 1991 Nov; 9(3):165-76. PubMed ID: 1776129
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
Tonnaer JA; Ernste BH; Wester J; Kelder K
J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343
[TBL] [Abstract][Full Text] [Related]
3. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
4. Characterization of [3H]AF-DX 116 binding sites in the rat brain: evidence for heterogeneity of muscarinic-M2 receptor sites.
Araujo DM; Lapchak PA; Regenold W; Quirion R
Synapse; 1989; 4(2):106-14. PubMed ID: 2781463
[TBL] [Abstract][Full Text] [Related]
5. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptor subtypes in human nasal mucosa: characterization, autoradiographic localization, and function in vitro.
Okayama M; Mullol J; Baraniuk JN; Hausfeld JN; Feldman B; Merida M; Shelhamer JH; Kaliner MA
Am J Respir Cell Mol Biol; 1993 Feb; 8(2):176-87. PubMed ID: 8427708
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic characterization of muscarinic receptors of insect brains.
Abdallah EA; Eldefrawi ME; Eldefrawi AT
Arch Insect Biochem Physiol; 1991; 17(2-3):107-18. PubMed ID: 1802028
[TBL] [Abstract][Full Text] [Related]
8. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
Norman AB; Creese I
Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
[TBL] [Abstract][Full Text] [Related]
9. Characterization and autoradiographic distribution of [3H]AF-DX 384 binding to putative muscarinic M2 receptors in the rat brain.
Aubert I; Cécyre D; Gauthier S; Quirion R
Eur J Pharmacol; 1992 Jul; 217(2-3):173-84. PubMed ID: 1425938
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
11. Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1985 Jul; 234(1):37-44. PubMed ID: 3839265
[TBL] [Abstract][Full Text] [Related]
12. Regional binding of 4-diphenylacetoxy-N-methylpiperidine methobromide (4-DAMP) to muscarinic receptors in rat brain and comparative analysis of minimum energy conformations.
Collins D; Smith DA; Messer WS
Neurochem Int; 1993 Mar; 22(3):237-47. PubMed ID: 8443567
[TBL] [Abstract][Full Text] [Related]
13. Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
Flynn DD; Mash DC
Synapse; 1993 Aug; 14(4):283-96. PubMed ID: 8248852
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic M2 receptors in rat brain labeled with [3H] AF-DX 384.
Castoldi AF; Fitzgerald B; Manzo L; Tonini M; Costa LG
Res Commun Chem Pathol Pharmacol; 1991 Dec; 74(3):371-4. PubMed ID: 1775727
[TBL] [Abstract][Full Text] [Related]
15. AF-DX 384 binding in rabbit cingulate cortex: two site kinetics and section autoradiography.
Dopke KL; Vrana KE; Vogt LJ; Vogt BA
J Pharmacol Exp Ther; 1995 Jul; 274(1):562-9. PubMed ID: 7616446
[TBL] [Abstract][Full Text] [Related]
16. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
17. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
Norman AB; Eubanks JH; Creese I
J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
[TBL] [Abstract][Full Text] [Related]
18. Differential ontogeny of putative M1 and M2 muscarinic receptor binding sites in the murine cerebral cortex and heart.
Evans RA; Watson M; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1985 Dec; 235(3):612-8. PubMed ID: 3841156
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic M1 and M3 receptors in rat striatum: a binding study.
de la Vega MT; Nuñez A; Arias-Montaño JA
Arch Med Res; 1997; 28(4):493-7. PubMed ID: 9428572
[TBL] [Abstract][Full Text] [Related]
20. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
Cortés R; Probst A; Tobler HJ; Palacios JM
Brain Res; 1986 Jan; 362(2):239-53. PubMed ID: 3753655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
